We invite you to join us for this live virtual meeting with presentations and discussions on ‘The changing landscape of Waldenström’s Macroglobulinemia (WM)’. Hosted by expert healthcare professionals, we’ll also be speaking with a patient representative and involving you in the conversation through polls and questions.
This meeting has been accredited with 3.5 CPD points by The Faculty of Pharmaceutical Medicine.
Please register your intended attendance at this promotional meeting via this form. Registration will ensure you are sent the viewing link for the meeting.
Enter your email address to get started
Shirley D'Sa, MD, FRCP, FRCPath, is a Consultant Haematologist with a special interest in WM and runs the largest WM clinic in the UK at University College London Hospitals (UCLH). She leads on a research programme in WM and IgM-related neurological disorders, including Bing Neel syndrome as well as conducting clinical trials of novel agents.
Dr Dima El-Sharkawi is a haematology consultant at the Royal Marsden Hospital. Her specialist interest is lymphoma including WM, CLL and the mature lymphoid leukaemias. She is clinical lead for the SIHMDS (regional diagnostic laboratory) at the Royal Marsden Hospital. She is the lead for the clinical advisory board (CAB) for WMUK and is an author on the recently published guidelines for the diagnosis and management of WM.
Jaimal Kothari is a consultant haematologist based at Oxford University Hospitals and an Honorary Senior Lecturer in Haematology at The University of Oxford. He completed his haematology training at University College London Hospital, and has particular interests in Waldenstroms Macroglobulinaemia and multiple myeloma. He is Chief Investigator for the UK wide WM-Pembro clinical trial, for patients with relapsed WM and a senior author on the recently published BCSH guidelines for WM.
WMUK CEO
Consultant Haematologist at St. James University Hospital Institute of Oncology in Leeds, UK. He has a special interest in indolent lymphoma including Waldenstroms macroglobulinaemia and marginal zone lymphoma.
Guy Pratt is a Consultant Haematologist in Birmingham with a strong clinical and research interest in Multiple Myeloma, Waldenstroms Macroglobulinaemia and related plasma cell disorders. He has an honorary title of Professor of Haematology from the University of Birmingham. He was clinical lead for the 2016 NICE myeloma guidelines and has had a number of positions nationally including vice-chair of BSH guidelines, ex-chair of the BSH science and publication committee.
Professor Con Tam is Head of the Lymphoma Service, Alfred hospital and Professor of Haematology, Monash University. after his training in Haematology and Haematopathology, con completed a Leukemia Fellowship at MD Anderson Cancer Centre in USA. Con is passionate about developing new therapies for the treatment of leukemias and lymphomas. He has published 240 peer-reviewed papers and his work has been cited >17,000 times.
